NewGenIvf Group Limited (NIVF) Stock Analysis & Investment Frameworks
NewGenIvf Group Limited (NIVF) stock analysis on Invetso. Review NewGenIvf Group Limited’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
NewGenIvf Group Limited Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Medical - Care Facilities
- Country: TH
NewGenIvf Group Limited Key Financial Metrics
- Market Cap: $66961.00
- Revenue: $4.73M
- P/E Ratio: 0.01
- ROE: 32.69%
- ROIC: -24.27%
- Dividend Yield: N/A
About NewGenIvf Group Limited
Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.
NewGenIvf Group Limited Investment Frameworks
Invetso analyzes NewGenIvf Group Limited (NIVF) across the following frameworks:
- NewGenIvf Group Limited 10Y Growth Potential
- NewGenIvf Group Limited Scenario Analysis
- NewGenIvf Group Limited Risks & Opportunities
- NewGenIvf Group Limited Economic Moat
- NewGenIvf Group Limited Business Model
- NewGenIvf Group Limited Management
- NewGenIvf Group Limited SWOT Analysis
- NewGenIvf Group Limited Porter's 5 Forces
- NewGenIvf Group Limited PESTLE Analysis
- NewGenIvf Group Limited ESG Analysis
